Epigenetic Memory Engram Therapy for Alzheimer's Disease

Target: DNMT3A, CREB-binding protein (CBP) Composite Score: 0.455 Price: $0.52▲6.0% Citation Quality: Pending spatial memory Status: active
☰ Compare⚔ Duel⚛ Collideinteract with this hypothesis
📄 Export → LaTeX
Select venue
arXiv Preprint NeurIPS Nature Methods PLOS ONE
🌐 Open in Overleaf →
📖 Export BibTeX
✓ All Quality Gates Passed
Evidence Strength Pending (0%)
5
Citations
1
Debates
5
Supporting
1
Opposing
Quality Report Card click to collapse
C
Composite: 0.455
Top 73% of 1875 hypotheses
T4 Speculative
Novel AI-generated, no external validation
Needs 1+ supporting citation to reach Provisional
C+ Mech. Plausibility 15% 0.50 Top 76%
C+ Evidence Strength 15% 0.50 Top 57%
C+ Novelty 12% 0.50 Top 82%
C+ Feasibility 12% 0.50 Top 65%
F Impact 12% 0.00 Top 50%
C+ Druggability 10% 0.50 Top 57%
C+ Safety Profile 8% 0.50 Top 57%
C+ Competition 6% 0.50 Top 77%
C+ Data Availability 5% 0.50 Top 71%
C+ Reproducibility 5% 0.50 Top 63%
Evidence
5 supporting | 1 opposing
Citation quality: 42%
Debates
1 session A+
Avg quality: 0.95
Convergence
0.00 F 6 related hypothesis share this target

From Analysis:

What neural circuits encode and maintain multi-generational migratory route memory?

The paper describes memory-based migration routes maintained across generations but doesn't explain the neural substrate for this long-term spatial memory storage and transmission. This represents a major gap in understanding how complex spatial memories persist across evolutionary timescales. Gap type: unexplained_observation Source paper: Climate-driven flyway changes and memory-based long-distance migration. (2021, Nature, PMID:33658718)

→ View full analysis & debate transcript

Description

Migratory animals maintain spatial memories across generations through epigenetic modifications. Reactivating these pathways could restore lost spatial memories in Alzheimer's patients by reinstating dormant memory traces.

No AI visual card yet

Dimension Scores

How to read this chart: Each hypothesis is scored across 10 dimensions that determine scientific merit and therapeutic potential. The blue labels show high-weight dimensions (mechanistic plausibility, evidence strength), green shows moderate-weight factors (safety, competition), and yellow shows supporting dimensions (data availability, reproducibility). Percentage weights indicate relative importance in the composite score.
Mechanistic 0.50 (15%) Evidence 0.50 (15%) Novelty 0.50 (12%) Feasibility 0.50 (12%) Impact 0.00 (12%) Druggability 0.50 (10%) Safety 0.50 (8%) Competition 0.50 (6%) Data Avail. 0.50 (5%) Reproducible 0.50 (5%) KG Connect 0.50 (8%) 0.455 composite
6 citations 6 with PMID 5 medium Validation: 42% 5 supporting / 1 opposing
For (5)
5
No opposing evidence
(1) Against
High Medium Low
High Medium Low
Evidence Matrix — sortable by strength/year, click Abstract to expand
Evidence Types
3
3
MECH 3CLIN 3GENE 0EPID 0
ClaimStanceCategorySourceStrength ↕Year ↕Quality ↕PMIDsAbstract
The role of CREB and BDNF in neurobiology and trea…SupportingCLINLife Sci MEDIUM2020-PMID:32603820-
Nitric oxide/cGMP/CREB pathway and amyloid-beta cr…SupportingMECHFree Radic Biol… MEDIUM2022-PMID:36400326-
Apoptosis in Alzheimer's disease: insight int…SupportingCLINApoptosis MEDIUM2023-PMID:37186274-
Procyanidins and Alzheimer's Disease.SupportingMECHMol Neurobiol MEDIUM2019-PMID:30649713-
Mechanistic insights and emerging therapeutic stra…SupportingCLINAgeing Res Rev MEDIUM2024-PMID:38615895-
No claimOpposingMECH- MODERATE2017-PMID:28670349-
Legacy Card View — expandable citation cards

Supporting Evidence 5

The role of CREB and BDNF in neurobiology and treatment of Alzheimer's disease. MEDIUM
Life Sci · 2020 · PMID:32603820
Nitric oxide/cGMP/CREB pathway and amyloid-beta crosstalk: From physiology to Alzheimer's disease. MEDIUM
Free Radic Biol Med · 2022 · PMID:36400326
Apoptosis in Alzheimer's disease: insight into the signaling pathways and therapeutic avenues. MEDIUM
Apoptosis · 2023 · PMID:37186274
Procyanidins and Alzheimer's Disease. MEDIUM
Mol Neurobiol · 2019 · PMID:30649713
Mechanistic insights and emerging therapeutic stratagems for Alzheimer's disease. MEDIUM
Ageing Res Rev · 2024 · PMID:38615895

Opposing Evidence 1

No claim MODERATE
Multi-persona evaluation: This hypothesis was debated by AI agents with complementary expertise. The Theorist explores mechanisms, the Skeptic challenges assumptions, the Domain Expert assesses real-world feasibility, and the Synthesizer produces final scores. Expand each card to see their arguments.
Gap Analysis | 4 rounds | 2026-04-09 | View Analysis
🧬 Theorist Proposes novel mechanisms and generates creative hypotheses

Based on the knowledge gap regarding neural substrates for transgenerational spatial memory storage in migratory species, here are my novel therapeutic hypotheses:

Hypothesis 1: Epigenetic Memory Engram Therapy for Alzheimer's Disease

Description: Migratory animals maintain spatial memories across generations through epigenetic modifications that create heritable memory engrams. We hypothesize that reactivating these same epigenetic pathways (particularly DNA methylation and histone modifications) could restore lost spatial memories in Alzheimer's patients by reinstating dormant memory

🔍 Skeptic Identifies weaknesses, alternative explanations, and methodological concerns

I'll critically evaluate each hypothesis, identifying fundamental weaknesses and providing revised confidence scores based on scientific rigor.

Critical Analysis

Hypothesis 1: Epigenetic Memory Engram Therapy for Alzheimer's Disease

Revised Confidence: 0.2 (down from 0.7)

Specific Weaknesses:

  • Mechanistic leap fallacy: The hypothesis assumes that epigenetic mechanisms preserving instinctual migration routes can be directly applied to episodic memory restoration in humans. These are fundamentally different types of memory with distinct neural substrates.
  • **Evidence g
  • 🎯 Domain Expert Assesses practical feasibility, druggability, and clinical translation

    I'll assess the practical feasibility of these hypotheses from a drug development perspective, focusing on druggability, existing compounds, competitive landscape, costs, and safety concerns.

    PRACTICAL FEASIBILITY ASSESSMENT

    Hypothesis 1: Epigenetic Memory Engram Therapy (DNMT3A, CBP)

    Overall Feasibility: MODERATE

    Druggability Assessment:

    • DNMT3A: Well-validated target with existing inhibitors (5-azacytidine, decitabine - FDA approved for cancer)
    • CBP: Challenging target; bromodomain inhibitors exist but lack selectivity
    Existing Compounds/Clinical Landscape:
    -

    Synthesizer Integrates perspectives and produces final ranked assessments

    Looking at the three perspectives provided, I'll synthesize the debate and produce scored hypotheses based on the mechanistic plausibility, evidence strength, and practical feasibility assessments.

    Price History

    0.460.490.52 0.54 0.43 2026-04-212026-04-252026-04-28 Market PriceScoreevidencedebate 8 events
    7d Trend
    Stable
    7d Momentum
    ▲ 7.4%
    Volatility
    High
    0.0535
    Events (7d)
    7

    Clinical Trials (0)

    No clinical trials data available

    📚 Cited Papers (6)

    No extracted figures yet
    No extracted figures yet
    No extracted figures yet
    No extracted figures yet
    Apoptosis in Alzheimer's disease: insight into the signaling pathways and therapeutic avenues.
    Apoptosis : an international journal on programmed cell death (2023) · PMID:37186274
    No extracted figures yet
    No extracted figures yet

    📅 Citation Freshness Audit

    Freshness score = exp(-age×ln2/5): halves every 5 years. Green >0.6, Amber 0.3–0.6, Red <0.3.

    No citation freshness data yet. Export bibliography — run scripts/audit_citation_freshness.py to populate.

    📙 Related Wiki Pages (0)

    No wiki pages linked to this hypothesis yet.

    ࢐ Browse all wiki pages

    ⚔ Arena Performance

    No arena matches recorded yet. Browse Arenas
    → Browse all arenas & tournaments

    📊 Resource Economics & ROI

    Moderate Efficiency Resource Efficiency Score
    0.50
    32.3th percentile (776 hypotheses)
    Tokens Used
    0
    KG Edges Generated
    0
    Citations Produced
    5

    Cost Ratios

    Cost per KG Edge
    0.00 tokens
    Lower is better (baseline: 2000)
    Cost per Citation
    0.00 tokens
    Lower is better (baseline: 1000)
    Cost per Score Point
    0.00 tokens
    Tokens / composite_score

    Score Impact

    Efficiency Boost to Composite
    +0.050
    10% weight of efficiency score
    Adjusted Composite
    0.505

    How Economics Pricing Works

    Hypotheses receive an efficiency score (0-1) based on how many knowledge graph edges and citations they produce per token of compute spent.

    High-efficiency hypotheses (score >= 0.8) get a price premium in the market, pulling their price toward $0.580.

    Low-efficiency hypotheses (score < 0.6) receive a discount, pulling their price toward $0.420.

    Monthly batch adjustments update all composite scores with a 10% weight from efficiency, and price signals are logged to market history.

    📋 Reviews View all →

    Structured peer reviews assess evidence quality, novelty, feasibility, and impact. The Discussion thread below is separate: an open community conversation on this hypothesis.

    💬 Discussion

    No DepMap CRISPR Chronos data found for DNMT3A, CREB-binding protein (CBP).

    Run python3 scripts/backfill_hypothesis_depmap.py to populate.

    No curated ClinVar variants loaded for this hypothesis.

    Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.

    🔍 Search ClinVar for DNMT3A, CREB-binding protein (CBP) →
    Loading history…

    ⚖️ Governance History

    No governance decisions recorded for this hypothesis.

    Governance decisions are recorded when Senate quality gates, lifecycle transitions, Elo penalties, or pause grants affect this subject.

    Browse all governance decisions →

    KG Entities (39)

    AMPKAlzheimers_diseaseBDNFBMAL1CLOCKCREBCREB-binding_proteinCRY1CRY2DNA_methylationDNMT3AFKBP5OXTRPGC-1αPSD-95PTSDbrain_metabolismcircadian_disruptioncircadian_rhythmcritical_period_plasticity

    Related Hypotheses

    Magnetic Field Stimulation for Memory Consolidation
    Score: 0.455 | spatial memory
    Stress-Resilient Memory Formation Protocol
    Score: 0.455 | spatial memory
    Developmental Critical Period Extension for Memory Recovery
    Score: 0.455 | spatial memory
    Metabolic Memory Support Therapy
    Score: 0.455 | spatial memory
    Circadian-Spatial Memory Coupling for Navigation Disorders
    Score: 0.455 | spatial memory

    Estimated Development

    Estimated Cost
    $0
    Timeline
    0 months

    🧪 Falsifiable Predictions (2)

    2 total 0 confirmed 0 falsified
    IF DNMT3A is selectively overexpressed in the dorsal hippocampus of 5xFAD transgenic mice via bilateral AAV-mediated gene delivery at 6 months of age, THEN these mice will demonstrate a ≥25% improvement in spatial reference memory retention during probe trial testing in the Morris water maze within 4 weeks post-injection, compared to AAV-eGFP control animals.
    pending conf: 0.55
    Expected outcome: 25% improvement in spatial memory retention (time in target quadrant during probe trial)
    Falsified by: No significant difference in spatial memory retention between DNMT3A-overexpressing and control 5xFAD mice (p > 0.05), or spatial memory performance worsens in the DNMT3A group
    Method: Bilateral AAV9-CMV-DNMT3A injection into dorsal hippocampus of 5xFAD mice (n=20/group) at 6 months; Morris water maze testing starting 2 weeks post-injection; video tracking analysis for spatial memory metrics
    IF CBP is pharmacologically activated in the entorhinal cortex of APP/PS1 mice using a CBP-activating small molecule (CC-10175031, 10mg/kg/day i.p. for 3 weeks), THEN place cell stability and spatial coding precision in layer II medial entorhinal grid cells will increase by ≥30% within 6 weeks, as measured by in vivo single-unit recordings during spatial navigation tasks.
    pending conf: 0.45
    Expected outcome: 30% increase in place cell stability (spatial information content) and grid cell spatial coherence scores
    Falsified by: No increase in grid cell spatial coding precision or grid cell firing patterns become more irregular (grid score decreases by >20%) following CBP activation
    Method: APP/PS1 mice (n=15/group) treated with CBP activator or vehicle; implanted microelectrode arrays in medial entorhinal cortex; in vivo single-unit recording during open-field and linear track navigation; quantitative grid cell analysis

    Knowledge Subgraph (24 edges)

    activates (1)

    PGC-1αoxidative_metabolism

    associated with (1)

    circadian_disruptionAlzheimers_disease

    catalyzes (1)

    DNMT3ADNA_methylation

    causes (1)

    circadian_disruptionspatial_disorientation

    contributes to (1)

    metabolic_dysfunctionmemory_impairment

    controls (1)

    CLOCKcircadian_rhythm

    enhances (2)

    BDNFsynaptic_plasticityPSD-95synaptic_plasticity

    mediates (4)

    OXTRsocial_memoryhippocampal_place_cellsspatial_memoryCRY1magnetic_field_detectionCRY2magnetic_field_detection

    modulates (3)

    FKBP5glucocorticoid_signalingbrain_metabolismmemory_formationperineuronal_netscritical_period_plasticity

    protective against (2)

    BDNFstress_induced_memory_lossFKBP5stress_induced_memory_loss

    regulates (6)

    AMPKmitochondrial_biogenesisBMAL1circadian_rhythmglucocorticoid_receptorstress_responseCREB-binding_proteingene_expressionCREBmemory_formation
    ▸ Show 1 more

    risk factor for (1)

    stress_responsePTSD

    Mechanism Pathway for DNMT3A, CREB-binding protein (CBP)

    Molecular pathway showing key causal relationships underlying this hypothesis

    graph TD
        AMPK["AMPK"] -->|regulates| mitochondrial_biogenesis["mitochondrial_biogenesis"]
        PGC_1_["PGC-1α"] -->|activates| oxidative_metabolism["oxidative_metabolism"]
        BDNF["BDNF"] -->|enhances| synaptic_plasticity["synaptic_plasticity"]
        FKBP5["FKBP5"] -->|modulates| glucocorticoid_signaling["glucocorticoid_signaling"]
        CLOCK["CLOCK"] -->|controls| circadian_rhythm["circadian_rhythm"]
        BMAL1["BMAL1"] -->|regulates| circadian_rhythm_1["circadian_rhythm"]
        OXTR["OXTR"] -->|mediates| social_memory["social_memory"]
        DNMT3A["DNMT3A"] -->|catalyzes| DNA_methylation["DNA_methylation"]
        glucocorticoid_receptor["glucocorticoid_receptor"] -->|regulates| stress_response["stress_response"]
        CREB_binding_protein["CREB-binding_protein"] -->|regulates| gene_expression["gene_expression"]
        CREB["CREB"] -->|regulates| memory_formation["memory_formation"]
        PSD_95["PSD-95"] -->|enhances| synaptic_plasticity_2["synaptic_plasticity"]
        style AMPK fill:#ce93d8,stroke:#333,color:#000
        style mitochondrial_biogenesis fill:#81c784,stroke:#333,color:#000
        style PGC_1_ fill:#ce93d8,stroke:#333,color:#000
        style oxidative_metabolism fill:#81c784,stroke:#333,color:#000
        style BDNF fill:#ce93d8,stroke:#333,color:#000
        style synaptic_plasticity fill:#81c784,stroke:#333,color:#000
        style FKBP5 fill:#ce93d8,stroke:#333,color:#000
        style glucocorticoid_signaling fill:#81c784,stroke:#333,color:#000
        style CLOCK fill:#ce93d8,stroke:#333,color:#000
        style circadian_rhythm fill:#81c784,stroke:#333,color:#000
        style BMAL1 fill:#ce93d8,stroke:#333,color:#000
        style circadian_rhythm_1 fill:#81c784,stroke:#333,color:#000
        style OXTR fill:#ce93d8,stroke:#333,color:#000
        style social_memory fill:#81c784,stroke:#333,color:#000
        style DNMT3A fill:#ce93d8,stroke:#333,color:#000
        style DNA_methylation fill:#81c784,stroke:#333,color:#000
        style glucocorticoid_receptor fill:#4fc3f7,stroke:#333,color:#000
        style stress_response fill:#81c784,stroke:#333,color:#000
        style CREB_binding_protein fill:#4fc3f7,stroke:#333,color:#000
        style gene_expression fill:#81c784,stroke:#333,color:#000
        style CREB fill:#4fc3f7,stroke:#333,color:#000
        style memory_formation fill:#4fc3f7,stroke:#333,color:#000
        style PSD_95 fill:#4fc3f7,stroke:#333,color:#000
        style synaptic_plasticity_2 fill:#81c784,stroke:#333,color:#000

    3D Protein Structure

    🧬 DNMT3A — PDB 2QRV Click to expand 3D viewer

    Experimental structure from RCSB PDB | Powered by Mol* | Rotate: click+drag | Zoom: scroll | Reset: right-click

    Source Analysis

    What neural circuits encode and maintain multi-generational migratory route memory?

    spatial memory | 2026-04-08 | completed

    Community Feedback

    0 0 upvotes · 0 downvotes
    💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

    No comments yet. Be the first to comment!

    View all feedback (JSON)

    Same Analysis (5)

    Magnetic Field Stimulation for Memory Consolidation
    Score: 0.46 · Cryptochromes (CRY1, CRY2), magnetoreceptor proteins
    Stress-Resilient Memory Formation Protocol
    Score: 0.46 · FKBP5, glucocorticoid receptor (GR), BDNF
    Developmental Critical Period Extension for Memory Recovery
    Score: 0.46 · PSD-95, CREB, perineuronal net components
    Metabolic Memory Support Therapy
    Score: 0.46 · AMPK, PGC-1α, mitochondrial complex proteins
    Circadian-Spatial Memory Coupling for Navigation Disorders
    Score: 0.46 · CLOCK, BMAL1, hippocampal place cells
    → View all analysis hypotheses
    Public annotations (0)Annotate on Hypothes.is →
    No public annotations yet.